BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32408169)

  • 61. Mutations in KCNT1 cause a spectrum of focal epilepsies.
    Møller RS; Heron SE; Larsen LH; Lim CX; Ricos MG; Bayly MA; van Kempen MJ; Klinkenberg S; Andrews I; Kelley K; Ronen GM; Callen D; McMahon JM; Yendle SC; Carvill GL; Mefford HC; Nabbout R; Poduri A; Striano P; Baglietto MG; Zara F; Smith NJ; Pridmore C; Gardella E; Nikanorova M; Dahl HA; Gellert P; Scheffer IE; Gunning B; Kragh-Olsen B; Dibbens LM
    Epilepsia; 2015 Sep; 56(9):e114-20. PubMed ID: 26122718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
    Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
    Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.
    McPate MJ; Duncan RS; Hancox JC; Witchel HJ
    Br J Pharmacol; 2008 Nov; 155(6):957-66. PubMed ID: 18724381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. De novo KCNT1 mutations in early-onset epileptic encephalopathy.
    Ohba C; Kato M; Takahashi N; Osaka H; Shiihara T; Tohyama J; Nabatame S; Azuma J; Fujii Y; Hara M; Tsurusawa R; Inoue T; Ogata R; Watanabe Y; Togashi N; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    Epilepsia; 2015 Sep; 56(9):e121-8. PubMed ID: 26140313
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Potassium Channel Subfamily T Member 1(KCNT1) Pathological Variant Causing Epilepsy Of Infancy With Migrating Focal Seizures: A Case Report.
    Chand P; Angez M; Hameed AN; Kirmani S
    J Pak Med Assoc; 2023 Aug; 73(8):1720-1722. PubMed ID: 37697770
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
    Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
    Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intolerance to quinidine in a n-of-1 trial for KCNT1 associated epilepsy of infancy with migrating focal seizures.
    Hughes E; Oates S; Pal DK
    Seizure; 2022 Dec; 103():46-50. PubMed ID: 36279596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural basis of human Slo2.2 channel gating and modulation.
    Zhang J; Liu S; Fan J; Yan R; Huang B; Zhou F; Yuan T; Gong J; Huang Z; Jiang D
    Cell Rep; 2023 Aug; 42(8):112858. PubMed ID: 37494189
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cryo-EM Structure of K
    Asai T; Adachi N; Moriya T; Oki H; Maru T; Kawasaki M; Suzuki K; Chen S; Ishii R; Yonemori K; Igaki S; Yasuda S; Ogasawara S; Senda T; Murata T
    Structure; 2021 Mar; 29(3):203-212.e4. PubMed ID: 33450182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potassium Channel Gain of Function in Epilepsy: An Unresolved Paradox.
    Niday Z; Tzingounis AV
    Neuroscientist; 2018 Aug; 24(4):368-380. PubMed ID: 29542386
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High potency inhibition of hERG potassium channels by the sodium-calcium exchange inhibitor KB-R7943.
    Cheng H; Zhang Y; Du C; Dempsey CE; Hancox JC
    Br J Pharmacol; 2012 Apr; 165(7):2260-73. PubMed ID: 21950687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium.
    Wrighton DC; Muench SP; Lippiat JD
    Br J Pharmacol; 2015 Sep; 172(17):4355-63. PubMed ID: 26045093
    [TBL] [Abstract][Full Text] [Related]  

  • 74. VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons.
    Spitznagel BD; Mishra NM; Qunies AM; Prael FJ; Du Y; Kozek KA; Lazarenko RM; Denton JS; Emmitte KA; Weaver CD
    ACS Chem Neurosci; 2020 Nov; 11(21):3658-3671. PubMed ID: 33143429
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sodium-activated potassium channels moderate excitability in vascular smooth muscle.
    Li P; Halabi CM; Stewart R; Butler A; Brown B; Xia X; Santi C; England S; Ferreira J; Mecham RP; Salkoff L
    J Physiol; 2019 Oct; 597(20):5093-5108. PubMed ID: 31444905
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population.
    Qu J; Zhang Y; Yang ZQ; Mao XY; Zhou BT; Yin JY; He H; Li XP; Long HY; Lv N; Xu XJ; Xiao B; Zhang Y; Tang Q; Hu DL; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2014 Feb; 20(2):140-6. PubMed ID: 24279416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect.
    Yan M; Fan P; Shi Y; Feng L; Wang J; Zhan G; Li B
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27690007
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
    Sănchez-Chapula JA; Ferrer T; Navarro-Polanco RA; Sanguinetti MC
    Mol Pharmacol; 2003 May; 63(5):1051-8. PubMed ID: 12695533
    [TBL] [Abstract][Full Text] [Related]  

  • 79. BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.
    Zhang M; Korolkova YV; Liu J; Jiang M; Grishin EV; Tseng GN
    Biophys J; 2003 May; 84(5):3022-36. PubMed ID: 12719233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule.
    Pardo-Lopez L; Zhang M; Liu J; Jiang M; Possani LD; Tseng GN
    J Biol Chem; 2002 May; 277(19):16403-11. PubMed ID: 11864985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.